EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Review of the limitations of current biomarkers in acute kidney injury clinical practices

Kendra B Bufkin iD, Zubair A Karim, Jeane Silva

SAGE Open Medicine · 2024-01 · 12

DOI: 10.1177/20503121241228446 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift SAGE Open Medicine, online erschienen am 05.02.2024. Verfasst von Kendra B Bufkin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Health Science, College of Allied Health Science, Augusta University, Augusta, GA, USA. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury is a prevalent disease in hospitalized patients and is continuously increasing worldwide. Various efforts have been made to define and classify acute kidney injury to understand the progression of this disease. Furthermore, deviations from structure and kidney function and the current diagnostic guidelines are not adequately placed due to baseline serum creatinine values, which are rarely known and estimated based on glomerular function rate, resulting in misclassification of acute kidney injury staging. Hence, the current guidelines are still developing to improve and understand the clinical implications of risk factors and earlier predictive biomarkers of acute kidney injury. Yet, studies have indicated disadvantages and limitations with the current acute kidney injury biomarkers, including lack of sensitivity and specificity. Therefore, the present narrative review brings together the most current evidenced-based practice and literature associated with the limitations of the gold standard for acute kidney injury diagnoses, the need for novel acute kidney injury biomarkers, and the process for biomarkers to be qualified for diagnostic use under the following sections and themes. The introduction section situates the anatomy and normal and abnormal kidney functions related to acute kidney injury disorders. Guidelines in providing acute kidney injury definitions and classification are then considered, followed by a discussion of the disadvantages of standard markers used to diagnose acute kidney injury. Characteristics of an ideal acute kidney injury biomarker are discussed concerning sensitivity, specificity, and anatomic location of injury. A particular focus on the role and function of emerging biomarkers is discussed in relation to their applications and significance to the prognosis and severity of acute kidney injury. Findings show emerging markers are early indicators of acute kidney injury prediction in different clinical settings. Finally, the process required for a biomarker to be applied for diagnostic use is explained.

Schlagwörter

Stichwörter der Autor:innen

Kidneyacutebiomarkerbiomarker discovery and developmentideallimitationsrenal

Autor:innen und Institutionen

  • Department of Interdisciplinary Health Science, College of Allied Health Science, Augusta University, Augusta, GA, USA.
  • Department of Health Management, Economics and Policy, Augusta University, Augusta, GA, USA.

ORCID-Profile: Kendra B Bufkin

Zitieren

APA

Bufkin, K. B., Karim, Z. A., & Silva, J. (2024). Review of the limitations of current biomarkers in acute kidney injury clinical practices. SAGE Open Medicine, 12. https://doi.org/10.1177/20503121241228446

Vancouver

Bufkin KB, Karim ZA, Silva J. Review of the limitations of current biomarkers in acute kidney injury clinical practices. SAGE Open Medicine. 2024;12. doi:10.1177/20503121241228446

BibTeX
@article{Bufkin2024,
  author = {Bufkin, Kendra B and Karim, Zubair A and Silva, Jeane},
  title = {Review of the limitations of current biomarkers in acute kidney injury clinical practices},
  journal = {SAGE Open Medicine},
  year = {2024},
  volume = {12},
  doi = {10.1177/20503121241228446}
}
Kostenlos starten →